Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma

被引:0
|
作者
Markus W. Löffler
Christopher Mohr
Leon Bichmann
Lena Katharina Freudenmann
Mathias Walzer
Christopher M. Schroeder
Nico Trautwein
Franz J. Hilke
Raphael S. Zinser
Lena Mühlenbruch
Daniel J. Kowalewski
Heiko Schuster
Marc Sturm
Jakob Matthes
Olaf Riess
Stefan Czemmel
Sven Nahnsen
Ingmar Königsrainer
Karolin Thiel
Silvio Nadalin
Stefan Beckert
Hans Bösmüller
Falko Fend
Ana Velic
Boris Maček
Sebastian P. Haen
Luigi Buonaguro
Oliver Kohlbacher
Stefan Stevanović
Alfred Königsrainer
Hans-Georg Rammensee
机构
[1] University Hospital Tübingen,Department of General, Visceral and Transplant Surgery
[2] University of Tübingen,Interfaculty Institute for Cell Biology, Department of Immunology
[3] German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) Partner Site Tübingen,Department of Clinical Pharmacology
[4] University Hospital Tübingen,Institute for Translational Bioinformatics
[5] University Hospital Tübingen,Quantitative Biology Center (QBiC)
[6] University of Tübingen,Center for Bioinformatics
[7] University of Tübingen,Department of Computer Science
[8] Applied Bioinformatics,Institute of Medical Genetics and Applied Genomics
[9] Present address: European Molecular Biology Laboratory,NGS Competence Center Tübingen (NCCT)
[10] European Bioinformatics Institute (EMBL-EBI),Present address: Department of General and Visceral Surgery
[11] University Hospital Tübingen,Institute of Pathology and Neuropathology
[12] Present address: Immatics Biotechnologies GmbH,Interfaculty Institute for Cell Biology, Proteome Center Tübingen (PCT)
[13] University of Tübingen,Internal Medicine, Department for Oncology, Hematology, Immunology, Rheumatology and Pulmonology
[14] Schwarzwald-Baar Hospital,Cancer Immunoregulation Unit
[15] University Hospital Tübingen,undefined
[16] University of Tübingen,undefined
[17] University of Tübingen,undefined
[18] Istituto Nazionale per lo Studio e la Cura dei Tumori,undefined
[19] “Fondazione Pascale” – IRCCS,undefined
[20] Max Planck Institute for Developmental Biology,undefined
[21] Biomolecular Interactions,undefined
来源
Genome Medicine | / 11卷
关键词
Hepatocellular carcinoma; HLA; HLA ligandomics; Immunoinformatics; Immunotherapy; Liver cancer; Mass spectrometry; Multi-omics; Neoantigen; Next-generation sequencing; Peptide prediction; Personalized medicine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Prognostic alternative splicing and multi-omics characteristics reveal FTCD is a potential target of hepatocellular carcinoma
    Zhang, Yanli
    Li, Wenxing
    Sun, Mengyi
    Zhang, Lisheng
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [42] Multi-omics Analysis Revealed the Diagnostic and Therapeutic Value of Immunogenic Cell Death-derived SCN5A in Hepatocellular Carcinoma
    Liang, Zicheng
    Tan, Wei
    Fang, Xiayi
    Zhang, Zhen
    Tan, Xiaoning
    Zeng, Puhua
    MOLECULAR BIOTECHNOLOGY, 2025,
  • [43] Abplatin(IV) inhibited tumor growth on a patient derived cancer model of hepatocellular carcinoma and its comparative multi-omics study with cisplatin
    Xing Li
    Lingpu Zhang
    Tuo Li
    Shumu Li
    Wenjing Wu
    Lingyu Zhao
    Peng Xie
    Jinqi Yang
    Peipei Li
    Yangyang Zhang
    Haihua Xiao
    Yingjie Yu
    Zhenwen Zhao
    Journal of Nanobiotechnology, 20
  • [44] Abplatin(IV) inhibited tumor growth on a patient derived cancer model of hepatocellular carcinoma and its comparative multi-omics study with cisplatin
    Li, Xing
    Zhang, Lingpu
    Li, Tuo
    Li, Shumu
    Wu, Wenjing
    Zhao, Lingyu
    Xie, Peng
    Yang, Jinqi
    Li, Peipei
    Zhang, Yangyang
    Xiao, Haihua
    Yu, Yingjie
    Zhao, Zhenwen
    JOURNAL OF NANOBIOTECHNOLOGY, 2022, 20 (01)
  • [45] Multi-omics approaches for biomarker discovery and precision diagnosis of prediabetes
    Song, Jielin
    Wang, Chuanfu
    Zhao, Tong
    Zhang, Yu
    Xing, Jixiang
    Zhao, Xuelian
    Zhang, Yunsha
    Zhang, Zhaohui
    FRONTIERS IN ENDOCRINOLOGY, 2025, 16
  • [46] On fusion methods for knowledge discovery from multi-omics datasets
    Baldwin, Edwin
    Han, Jiali
    Luo, Wenting
    Zhou, Jin
    An, Lingling
    Liu, Jian
    Zhang, Hao Helen
    Li, Haiquan
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2020, 18 (18): : 509 - 517
  • [47] Breakthroughs in AI and multi-omics for cancer drug discovery: A review
    Fatima, Israr
    Rehman, Abdur
    Ding, Yanheng
    Wang, Peng
    Meng, Yuxuan
    Rehman, Hafeez Ur
    Warraich, Dawood Ahmad
    Wang, Zhibo
    Feng, Lijun
    Liao, Mingzhi
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 280
  • [48] Decoding per- and polyfluoroalkyl substances (PFAS) in hepatocellular carcinoma: a multi-omics and computational toxicology approach
    Yanggang Hong
    Deqi Wang
    Zeyu Liu
    Yuxin Chen
    Yi Wang
    Jiajun Li
    Journal of Translational Medicine, 23 (1)
  • [49] Multi-omics identification of a polyamine metabolism related signature for hepatocellular carcinoma and revealing tumor microenvironment characteristics
    Yu, Yuexi
    Liu, Huiru
    Liu, Kaipeng
    Zhao, Meiqi
    Zhang, Yiyan
    Jiang, Runci
    Wang, Fengmei
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [50] Identifying tumor immunity-associated molecular features in liver hepatocellular carcinoma by multi-omics analysis
    Shen, Qianyun
    He, Yin
    Qian, Jiajie
    Wang, Xiaosheng
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9